SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

MORAES, Frederico Barra de et al. Miosite ossificante progressiva: relato de caso. Rev. bras. ortop. [online]. 2012, vol.47, n.3, pp.394-396. ISSN 0102-3616.

    1. Whyte MP. Heritable metabolic and dysplastic bone diseases. Endocrinol Metab Clin North Am. 1990;19(1):133-73. [ Links ]

    2. Patin G. Lettres choisis de feu M. Guy Patin. Letter of August 27, 1648, to AF. Cologne P. du Laurens, 1692. Tome 1, vol. 5, p. 28. [ Links ]

    3. Reinig JW, Hill SC, Fang M, Marini J, Zasloff MA. Fibrodysplasia ossificans progressiva: CT appearance. Radiology. 1986;159(1):153-7. [ Links ]

    4. Smith R, Russell RG, Woods CG. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment. J Bone Joint Surg Br. 1976;58(1):48-57. [ Links ]

    5. Rogers JG, Dorst JP, Geho WB. Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva. J Pediatr. 1977;91(6):1011-4. [ Links ]

    6. Bar Oz B, Boneh A. Myositis ossificans progressiva: a 10-year follow-up on a patient treated with etidronate disodium. Acta Paediatr. 1994;83(12):1332-4. [ Links ]

    7. McEvoy GK. Unclassified therapeutic agents. In: American Hospital Formulary Service (AHFS) Drug Information. Bethesda, Library of Congress, 2000,3399-403. [ Links ]

    8. Palhares DB. Myositis ossificans progressive. Calcif Tissue Int. 1997;60(4):394. [ Links ]

    9. Buyse G, Silberstein J, Goemans N, Casaer P. Fibrodysplasia ossificans progressiva: still turning into wood after 300 years? Eur J Pediatr. 1995;154(9):694-9. [ Links ]

    10. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br. 1982;64(1):76-83. [ Links ]

    11. Bullough P. Orthopaedic Pathology. 3a ed. London: Times Mirror International Publishers Limited; 1997. [ Links ]

    12. Palhares DB, Leme LM. [A perspective on the control of myositis ossificans progressiva]. J Pediatr (Rio Janeiro). 2001;77(5):431-4. [ Links ]

    13. Alpigiani MG, Puleo MG, Callegarini L, Di Bella E, Debbia C, Buzzanca C, et al. [Dichloromethylenbiphosphonic acid in the therapy of myositis ossificans progressive (MOP)]. Minerva Pediatr. 1996;48(4):159-63. [ Links ]